Diuretic or Beta-Blocker for Hypertensive Patients Already Receiving ACEI/ARB and Calcium Channel Blocker

Area of Science:

• Cardiology
• Pharmacology
• Public Health

Background:

• Hypertension management often involves multiple drug classes.
• The optimal choice of a third antihypertensive agent when ACEI/ARB and CCB are already used is unclear.
• Impact of adding a diuretic versus a beta-blocker on cardiovascular outcomes needs investigation.

Purpose of the Study:

• To compare cardiovascular and cerebrovascular outcomes in hypertensive patients receiving ACEI/ARB, CCB, plus either a diuretic or a beta-blocker.
• To assess the effect of adding a diuretic versus a beta-blocker on stroke, AMI, mortality, and MACE.

Main Methods:

• Retrospective cohort study of 13,551 Taiwanese patients (2004-2006) on three antihypertensive classes.
• Patients categorized into ACEI/ARB + CCB + Beta-blocker (A+B+C) or ACEI/ARB + CCB + Diuretic (A+C+D) groups.
• Propensity score matching used to compare event-free survival for stroke, AMI, mortality, and MACE.

Main Results:

• After matching, 5120 patients were in each group; no overall cardiovascular event differences were found.
• In patients with a prior history of cerebrovascular accident (CVA), the diuretic group (A+C+D) had significantly higher AMI-free survival (adjusted HR=1.56).
• No significant differences in stroke-free survival or mortality were observed between groups.

Conclusions:

• Adding a diuretic may be more beneficial than adding a beta-blocker for hypertensive patients with prior CVA history already on ACEI/ARB and CCB.
• This suggests a potential benefit of diuretics in specific high-risk hypertensive populations.
• Further research is warranted to confirm these findings and elucidate underlying mechanisms.